1. Home
  2. RES vs VIR Comparison

RES vs VIR Comparison

Compare RES & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$6.95

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
VIR
Founded
1984
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
RES
VIR
Price
$6.95
$8.76
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$5.64
$19.43
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
2.02%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$41,919,000,000.00
$68,556,000.00
Revenue This Year
$3.29
$270.22
Revenue Next Year
$4.05
N/A
P/E Ratio
$45.40
N/A
Revenue Growth
2216.21
N/A
52 Week Low
$4.18
$4.16
52 Week High
$8.16
$11.66

Technical Indicators

Market Signals
Indicator
RES
VIR
Relative Strength Index (RSI) 44.46 36.96
Support Level $6.42 $8.47
Resistance Level $7.41 $10.29
Average True Range (ATR) 0.27 0.43
MACD -0.11 -0.18
Stochastic Oscillator 10.32 4.20

Price Performance

Historical Comparison
RES
VIR

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: